¼Û½ÂÈÆ
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : ºÎÀÎÁ¾¾çÇÐ, ·Îº¿¼ö¼ú
Á÷
ˤ
: ±³¼ö
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
23
ÇØ¿Ü
The expression of p 16 (INK 4a) and Ki-67 in relation to high-risk human papilloma viral load and residual disease after conization with positive margins.
22
ÇØ¿Ü
The relationship between cytokines and HPV 16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix.
21
ÇØ¿Ü
The expression of epidermal growth factor receptor, vascular endothelial growth factor, matrix metalloproteinase-2, and cyclooxygenase-2 in relation to human papilloma viral load and persistence of human papillomavirus after conization with negative margins.
20
±¹³»
Peutz-Jeghers Syndrome with multiple genital tract tumors and breast cancer: a case report with a review of literatures
19
ÇØ¿Ü
Risk factors for the progression or persistence of untreated mild dysplasia of the uterine cervix
18
ÇØ¿Ü
Persistent HPV infection after conization in patients with negative margins
17
±¹³»
1±â ¹× 2±â Àڱ󻸷¾Ï 59¿¹ÀÇ ÀÓ»óº´¸®ÇÐÀû Ư¡ ¹× ¿¹ÈÄ ÀÎÀÚ¿¡ °üÇÑ ¿¬±¸
16
±¹³»
Àӻ󿬱¸: ÀڱðæºÎ ¼¼Æ÷ °Ë»ç»ó ÀÌ»ó ¼±¼¼Æ÷¿¡¼ °íµî±Þ º´º¯ÀÇ À§Çè ÀÎÀÚ
15
±¹³»
ÃÖ±Ù 15³â°£ Çѱ¹¿¡¼ÀÇ Àڱ󻸷¾ÏÀÇ »ýÁ¸À² ¹× Ä¡·á ¹æ¹ýÀÇ º¯È
14
±¹³»
ÀڱðæºÎ¼±¾Ï 80¿¹ÀÇ ÀÓ»óº´¸®ÇÐÀû Ư¼º ¹× ¿¹ÈÄ ÀÎÀÚ¿¡ °üÇÑ ¿¬±¸
1
2
3
4
5
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729